Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity

Cited by (1,004)

Items 601–700 of 1,004

  1. mRNA vaccines: A matter of delivery
    Yuhong Cao, George F. Gao · 2021 · EClinicalMedicine
  2. N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products
    Kyusik Q. Kim, Bhagyashri D. Burgute, Shin‐Cheng Tzeng, Crystal Jing, Courtney F. Jungers, Junya Zhang, Liewei L. Yan, Richard David Vierstra, Sergej Djuranović, Bradley S. Evans et al. · 2022 · Cell Reports
  3. mRNA-Based Therapeutics in Cancer Treatment
    Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu · 2023 · Pharmaceutics
  4. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
    Laura Matarazzo, Paulo J. G. Bettencourt · 2023 · Frontiers in Immunology
  5. The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system
    Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot, Katia Lemdani, Sylvie Commandeur, Cécile Verdelet, Sylvie Margot, Vladimir Perkov, Manon Ripoll, Marie Garinot et al. · 2023 · Molecular Therapy — Nucleic Acids
  6. mRNA therapies: Pioneering a new era in rare genetic disease treatment
    Guobo Shen, Jian Liu, Hanmei Yang, Na Xie, Yang Yang · 2024 · Journal of Controlled Release
  7. Advances and prospects of RNA delivery nanoplatforms for cancer therapy
    Mohamed S. Attia, Gregor Stefan Kijanka, Nam‐Trung Nguyen, Jun Zhang, Hongjie An · 2024 · Acta Pharmaceutica Sinica B
  8. 2'-O-Methylation within Bacterial RNA Acts as Suppressor of TLR7/TLR8 Activation in Human Innate Immune Cells
    Katharina Rimbach, Steffen Kaiser, Mark Helm, Alexander H. Dalpke, Tatjana Eigenbrod · 2015 · Journal of Innate Immunity
  9. A High-Throughput Quantitative Approach Reveals More Small RNA Modifications in Mouse Liver and Their Correlation with Diabetes
    Menghong Yan, Yuangao Wang, Yanan Hu, Yan Feng, Changgui Dai, Jingxia Wu, Dongmei Wu, Fang Zhang, Qiwei Zhai · 2013 · Analytical Chemistry
  10. An Improved, Chemically Modified RNA Encoding BMP-2 Enhances Osteogenesis In Vitro and In Vivo
    Wen Zhang, Rodolfo E. De la Vega, Michael J. Coenen, Sebastian Müller, Carlos Julio Peniche Silva, Manish Kumar Aneja, Christian Plank, Martijn van Griensven, Christopher H. Evans, Elizabeth Rosado Balmayor · 2018 · Tissue Engineering Part A
  11. Unveiling the druggable RNA targets and small molecule therapeutics
    Joanna Sztuba-Solińska, Gabriela Chávez‐Calvillo, Sabrina Elizabeth Cline · 2019 · Bioorganic & Medicinal Chemistry
  12. RNA modification in mRNA cancer vaccines
    Yingxue Mei, Xiang Wang · 2023 · Clinical and Experimental Medicine
  13. Ongoing Clinical Trials of Nonviral siRNA Therapeutics
    Eshan A. Narasipura, Rachel VanKeulen‐Miller, Yutian Ma, Owen S. Fenton · 2023 · Bioconjugate Chemistry
  14. Understanding the impact of in vitro transcription byproducts and contaminants
    Robin Lenk, Werner Kleindienst, Gábor Tamás Szabó, Markus Baiersdörfer, Gábor Boros, Jason M. Keller, Azita J. Mahiny, Irena Vlatkovic · 2024 · Frontiers in Molecular Biosciences
  15. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells
    Evelien Smits, Nathalie Cools, Eva Lion, Kirsten Van Camp, Peter Ponsaerts, Zwi Nisan Berneman, Viggo F. Van Tendeloo · 2009 · Cancer Immunology Immunotherapy
  16. mRNA
    Sandra Van Lint, Carlo Heirman, Kris Thielemans, Karine Breckpot · 2013 · Human Vaccines & Immunotherapeutics
  17. The mRNA-LNP vaccines – the good, the bad and the ugly?
    Botond Z. Igyártó, Zhen Qin · 2024 · Frontiers in Immunology
  18. Crystal structure of the RNA demethylase ALKBH5 from zebrafish
    Weizhong Chen, Liang Zhang, Guanqun Zheng, Ye Fu, Quanjiang Ji, Fange Liu, Hao Chen, Chuan He · 2014 · FEBS Letters
  19. Induced packaging of mRNA into polyplex micelles by regulated hybridization with a small number of cholesteryl RNA oligonucleotides directed enhanced in vivo transfection
    Naoto Yoshinaga, Satoshi Uchida, Mitsuru Naito, Kensuke Osada, Horacio Cabral, Kazunori Kataoka · 2019 · Biomaterials
  20. Toll-like receptors and innate immune responses in systemic lupus erythematosus
    Robert Lafyatis, Ann Marshak‐Rothstein · 2007 · Arthritis Research & Therapy
  21. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
    Wolfgang A. Schulz, Adrian Alexa, Volker Jung, Christiane Hader, Michèle J. Hoffmann, Masanori Yamanaka, Sandy Fritzsche, Agnes Wlazlinski, Mirko Müller, Thomas Lengauer et al. · 2007 · Molecular Cancer
  22. CureVac COVID vaccine let-down spotlights mRNA design challenges
    Elie Dolgin · 2021 · Nature
  23. Chemical Modification of Small Interfering RNA
    Jesper B. Bramsen, Jørgen Kjems · 2011 · Methods in molecular biology
  24. Current progress in the development of prophylactic and therapeutic vaccines
    Tingting Li, Ciying Qian, Ying Gu, Jun Zhang, Shaowei Li, Ningshao Xia · 2022 · Science China Life Sciences
  25. RNA vaccines for cancer: Principles to practice
    Pablo Guasp, Charlotte Reiche, Zachary M. Sethna, Vinod P. Balachandran · 2024 · Cancer Cell
  26. mRNA, a Revolution in Biomedicine
    Bruno Baptista, Rita Carapito, Nabila Laroui, Chantal Pichon, Fani Pereira de Sousa · 2021 · Pharmaceutics
  27. Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
    Yusi Wang, Rui Zhang, Lin Tang, Yang Li · 2022 · Pharmaceutics
  28. Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
    Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He · 2023 · Biomarker Research
  29. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  30. Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment
    Theofilus A. Tockary, Saed Abbasi, Miki Matsui-Masai, Akimasa Hayashi, Naoto Yoshinaga, Eger Boonstra, Zheng Wang, Shigeto Fukushima, Kazunori Kataoka, Satoshi Uchida · 2023 · Proceedings of the National Academy of Sciences
  31. Clinical development of therapeutic mRNA applications
    Magdalena M. Żak, Lior Zangi · 2025 · Molecular Therapy
  32. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement
    Marleen Bérouti, Mirko Wagner, Wilhelm Greulich, Ignazio Piseddu, Jan Gärtig, Larissa Hansbauer, Christoph Müller-Hermes, Matthias Heiß, Alexander Pichler, Annika J. Tölke et al. · 2025 · Cell
  33. A novel pathogenetic concept—antiviral immunity in lupus nephritis
    Adriana Migliorini, Hans‐Joachim Anders · 2012 · Nature Reviews Nephrology
  34. RAGE Enhances TLR Responses through Binding and Internalization of RNA
    Damien Bertheloot, Allison L Naumovski, Pia Langhoff, Gabor L Horvath, Tengchuan Jin, Tsan Sam Xiao, Natalio Garbi, Sudhir Agrawal, Roland Kolbeck, Eicke Latz · 2016 · The Journal of Immunology
  35. Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
    Oh, Sanders, Kessler, John A. · 2018 · Methods
  36. Eukaryotic Translation Elongation is Modulated by Single Natural Nucleotide Derivatives in the Coding Sequences of mRNAs
    Thomas Philipp Hoernes, David Heimdörfer, Daniel Kostner, Klaus Faserl, Felix Nußbaumer, Raphael Plangger, Christoph Kreutz, Herbert H. Lindner, Matthias David Erlacher · 2019 · Genes
  37. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
    Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, Henri Estanbouli, Aurélie Bouteau, Botond Z. Igyártó · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  38. N6-Methyladenosine Regulates Host Responses to Viral Infection
    Michael J. McFadden, Stacy M. Horner · 2020 · Trends in Biochemical Sciences
  39. Chemo‐Enzymatic Modification of the 5′ Cap Maintains Translation and Increases Immunogenic Properties of mRNA
    Melissa van Dülmen, Nils Muthmann, Andrea Rentmeister · 2021 · Angewandte Chemie International Edition
  40. Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
    Jie Tang, Larry Cai, Chuanfei Xu, Si Sun, Yuheng Liu, Joseph Rosenecker, Shan Guan · 2022 · Nanomaterials
  41. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
    Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, Cristian Smerdou · 2024 · Vaccines
  42. Systematic discovery of CRISPR-boosted CAR T cell immunotherapies
    Paul Datlinger, Eugenia V. Pankevich, Cosmas D. Arnold, Nicole Pranckevicius, Jenny Lin, Daria Romanovskaia, Moritz Schaefer, Francesco Piras, Anne-Christine Orts, Amelie Nemc et al. · 2025 · Nature
  43. Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium
    Paul J. McKiernan, Kevin Molloy, Sally‐Ann Cryan, Noel Gerard McElvaney, Catherine M. Greene · 2014 · The International Journal of Biochemistry & Cell Biology
  44. The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure
    Baptiste Martin, Bruno Coutard, Théo Guez, Guido C. Paesen, Bruno Canard, Françoise Debart, Jean‐Jacques Vasseur, Jonathan M. Grimes, Étienne Decroly · 2018 · Nucleic Acids Research
  45. Chemically Modified Short Interfering Hybrids (siHYBRIDS): Nanoimmunoliposome DeliveryIn VitroandIn Vivofor RNAi of HER-2
    Richard I. Hogrefe, Alexandre V. Lebedev, Gerald Zon, Kathleen F. Pirollo, Antonina S. Rait, Qi Zhou, Wei Yu, Esther H. Chang · 2006 · Nucleosides Nucleotides & Nucleic Acids
  46. A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics
    Huanhuan Y. Wei, Chuyun Chen, Kai Zhang, Zeyang Li, Tong Wei, Chenxiang Tang, Yun Yang, Zefeng Wang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  47. COVID-19 vaccine platforms: Delivering on a promise?
    Mark A. Verdecia, John F. Kokai‐Kun, Maura Kibbey, Sarita Acharya, Jaap Venema, Fouad Atouf · 2021 · Human Vaccines & Immunotherapeutics
  48. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
    Amanda L. Huff, Elizabeth M. Jaffee, Neeha Zaidi · 2022 · Journal of Clinical Investigation
  49. Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
    Mohammad Mostafa Pourseif, Yosef Masoudi‐Sobhanzadeh, Erfan Azari, Sepideh Parvizpour, Jaleh Barar, Rais Ahmad Ansari, Yadollah Omidi · 2022 · Drug Discovery Today
  50. Research progress on circular RNA vaccines
    Yu Bai, Dong Liu, Qian He, Jianyang Liu, Qunying Mao, Zhenglun Liang · 2023 · Frontiers in Immunology
  51. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
    Mariana Biscaia-Caleiras, Nuno André Fonseca, Ana Sofia Lourenço, João Nuno Moreira, Sérgio Simões · 2024 · Journal of Controlled Release
  52. Forkhead Box P3 Regulates TLR10 Expression in Human T Regulatory Cells
    Michael P. Bell, Phyllis A. Svingen, Meher K. Rahman, Yuning Xiong, William A. Faubion · 2007 · The Journal of Immunology
  53. Pseudoviral immunity – a novel concept for lupus
    Hans‐Joachim Anders · 2009 · Trends in Molecular Medicine
  54. A multifunctional bioconjugate module for versatile photoaffinity labeling and click chemistry of RNA
    Stefanie M. Kellner, Salifu Seidu‐Larry, Jürgen Burhenne, Yuri Motorin, Mark Helm · 2011 · Nucleic Acids Research
  55. Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
    Ariane Cruz Gomes, Elisa S. Roesti, Aadil El-Turabi, Martin F. Bachmann · 2019 · Vaccines
  56. Generation of Chemically Unmodified Pure Single‐Walled Carbon Nanotubes by Solubilizing with RNA and Treatment with Ribonuclease A
    J. Charles G. Jeynes, Ernest Mendoza, D. C. S. Chow, P. C. P. Watts, Johnjoe McFadden, S. Ravi P. Silva · 2006 · Advanced Materials
  57. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
    Elias Fattal, François Fay · 2021 · Advanced Drug Delivery Reviews
  58. mRNA vaccine designs for optimal adjuvanticity and delivery
    Yuki Mochida, Satoshi Uchida · 2024 · RNA Biology
  59. 2′- O -methylation (Nm) in RNA: progress, challenges, and future directions
    Katherine Ismei Zhou, Chad Victor Pecot, Christopher L. Holley · 2024 · RNA
  60. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo
    Qiannan Cao, Huapan Fang, Huayu Tian · 2024 · Biomaterials
  61. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
    Máté Vadovics, Wenchen Zhao, Emily F. Daley, Kieu Lam, Owen M. Daly, Khalid Rashid, Hailey R. Lee, Petra Schreiner, Kendall A. Lundgreen, Brian T. Gaudette et al. · 2025 · Nature Nanotechnology
  62. siRNA Delivery with Lipid-based Systems: Promises and Pitfalls
    Camilla Foged · 2012 · Current Topics in Medicinal Chemistry
  63. The Relevance of TLR8 in Viral Infections
    Iván Martínez-Espinoza, Antonieta Guerrero-Plata · 2022 · Pathogens
  64. Plasmacytoid dendritic cells in antiviral immunity and autoimmunity
    Fei Tang, Qiumei Du, Yongjun Liu · 2010 · Science China Life Sciences
  65. Cell Surface Expression of Endosomal Toll-Like Receptors—A Necessity or a Superfluous Duplication?
    Matylda Barbara Mielcarska, Magdalena Bossowska-Nowicka, Felix Ngosa Toka · 2021 · Frontiers in Immunology
  66. Nonsegmented Negative-Sense RNA Viruses Utilize N 6 -Methyladenosine (m 6 A) as a Common Strategy To Evade Host Innate Immunity
    Mijia Lu, Miaoge Xue, Hai-Tao Wang, Elizabeth L. Kairis, Sadeem Ahmad, Jiangbo Wei, Zijie Scott Zhang, Qinzhe Liu, Yuexiu Zhang, Youling Gao et al. · 2021 · Journal of Virology
  67. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
    Kimura, Taishi, Leal, Joseph M., Simpson, Adrian, Warner, Nikole L., Berube, Bryan J., Archer, Jacob F., Park, Stephanie, Kurtz, Ryan, Hinkley, Troy, Nicholes, Katrina et al. · 2023 · Molecular Therapy
  68. Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
    Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong et al. · 2022 · Advanced Science
  69. Analyzing immune responses to varied mRNA and protein vaccine sequences
    Hyeong-Jun Park, Yoo‐Jin Bang, Sung Pil Kwon, Woori Kwak, Sang‐In Park, Gahyun Roh, Seo‐Hyeon Bae, Jaeyong Kim, Hye Won Kwak, Yongkwan Kim et al. · 2023 · npj Vaccines
  70. Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives
    Xiaochi Li, Junli Li, Jiazheng Wei, Weixin Du, Cheng Su, Xiaobin Shen, Aihua Zhao, Miao Xu · 2025 · MedComm
  71. Modulation of B cell responses by Toll-like receptors
    Jayaum S. Booth, H. Wilson, S. Jimbo, G. Mutwiri · 2010 · Cell and Tissue Research
  72. Endogenous Retroelements and the Host Innate Immune Sensors
    Xin Ni Mu, Sadeem Ahmad, Sun Hur · 2016 · Advances in immunology
  73. Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination
    Satoshi Uchida, Naoto Yoshinaga, Kayoko Yanagihara, Eiji Yuba, Kazunori Kataoka, Keiji Itaka · 2017 · Biomaterials
  74. Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis
    Ranakul Islam, Lei Zhao, Yi-Fang Wang, Grace L. Lu-Yao, L.-Z. Liu · 2022 · Cancers
  75. High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
    Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, Hyomin Lee · 2023 · Advanced Healthcare Materials
  76. All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons
    Yangcan Chen, Shengqiu Luo, Yanping Hu, Bangwei Mao, Xinge Wang, Zongbao Lu, Qingtong Shan, Jin Zhang, Siqi Wang, Guihai Feng et al. · 2024 · Cell
  77. Monoclonal antibodies: From magic bullet to precision weapon
    Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, Lina M. Ismail, Adham Ezz El-Regal Mahmoud, Walid Faisal Elkhatib, Heba Aboul-Ella · 2024 · Molecular Biomedicine
  78. Efficient circular RNA synthesis for potent rolling circle translation
    Yifei Du, Philipp Konrad Zuber, Huajuan Xiao, Xueyan Li, Yuliya Gordiyenko, Venki Ramakrishnan · 2024 · Nature Biomedical Engineering
  79. Determinants of Cytokine Induction by Small Interfering RNA in Human Peripheral Blood Mononuclear Cells
    Maryam Zamanian-Daryoush, João Trindade Marques, Michael Paul Gantier, Mark A. Behlke, Matthias John, Patricia A. Rayman, James Harold Finke, Bryan R.G. Williams · 2008 · Journal of Interferon & Cytokine Research
  80. Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari
    Marco Quevedo-Díaz, Chang Hwa Song, Yanbao Xiong, Haiyan Chen, Larry M. Wahl, Suzana Radulović, Andrei E. Medvedev · 2010 · Journal of Leukocyte Biology
  81. Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression
    Meltem Avci‐Adali, Andreas Behring, Timea Keller, Stefanie Krajewski, Christian Schlensak, Hans Peter Wendel · 2014 · Journal of Biological Engineering
  82. Design of active small interfering RNAs.
    Andrew S. Peek, Mark A. Behlke · 2007 · PubMed
  83. In silico selection of active siRNA
    Volker Patzel · 2006 · Drug Discovery Today
  84. Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6
    Chin, Randall Marcelo, Panavas, Tadas, Brown, Jeffrey M., Johnson, Krista K. · 2018 · Cell Reports
  85. m6A: Widespread regulatory control in virus replication
    Oliver Manners, Belinda Baquero-Pérez, Adrian Whitehouse · 2018 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  86. An Update on mRNA-Based Viral Vaccines
    Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, Bao‐Zhong Wang, Sang‐Moo Kang · 2021 · Vaccines
  87. Modern therapeutic approaches to liver-related disorders
    Antoine Gardin, Katharina Remih, Emmanuel M. Gonzales, Emma Rachel Andersson, Pavel Strnad · 2022 · Journal of Hepatology
  88. mRNA vaccines in the prevention and treatment of diseases
    Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang, Xing Zhao · 2022 · MedComm
  89. Translation machinery: the basis of translational control
    Yuan Shu, Guilong Zhou, Guoyong Xu · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  90. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
    Yeung Wu, Sinuo Yu, Irene de Lázaro · 2024 · Nanoscale
  91. Stable Extracellular RNA Fragments of Mycobacterium tuberculosis Induce Early Apoptosis in Human Monocytes via a Caspase-8 Dependent Mechanism
    Andrés Obregón‐Henao, Maria Adelaida Duque Correa, Mauricio Rojas, Luis F. García, Patrick J. Brennan, Blanca L. Ortíz, John T. Belisle · 2012 · PLoS ONE
  92. Global DNA hypomethylation is an early event in Helicobacter pylori -related gastric carcinogenesis
    Debora Compare, Alba Rocco, Eleonora Liguori, Francesco Paolo D’Armiento, Giovanni Persico, Stefania Masone, Enrico Coppola Bottazzi, Renzo Suriani, Marco Romano, Gerardo Nardone · 2011 · Journal of Clinical Pathology
  93. Phenylpyrrolocytosine as an Unobtrusive Base Modification for Monitoring Activity and Cellular Trafficking of siRNA
    Alexander Sean Wahba, Fereshteh Azizi, Glen F. Deleavey, Claire M. Brown, Francis Robert, Marilyn Carrier, Anna Kalota, Alan M. Gewirtz, Jerry Pelletier, Robert H. E. Hudson et al. · 2011 · ACS Chemical Biology
  94. Translating the epitranscriptome
    Thomas Philipp Hoernes, Matthias David Erlacher · 2016 · Wiley Interdisciplinary Reviews - RNA
  95. aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model
    Jinmiao Chen, Qing Ma, Justin S. King, Yan Sun, Bing Xu, Xiaoyu Zhang, Sylvia Zohrabian, Haipeng Guo, Wenqing Cai, Gavin Li et al. · 2019 · Life Science Alliance
  96. Modified mRNA as a Therapeutic Tool for the Heart
    Keerat Kaur, Lior Zangi · 2020 · Cardiovascular Drugs and Therapy
  97. Pathogen Recognition: TLRs Throw Us a Curve
    Peter B. Kirk, J. Fernando Bazán · 2005 · Immunity
  98. Dead or alive: how the immune system detects microbial viability
    Matteo Ugolini, Leif Erik Sander · 2018 · Current Opinion in Immunology
  99. Next generation self-replicating RNA vectors for vaccines and immunotherapies
    Parinaz Aliahmad, Shigeki Joseph Miyake-Stoner, Andrew J. Geall, Nathaniel S. Wang · 2022 · Cancer Gene Therapy
  100. mRNA therapy at the convergence of genetics and nanomedicine
    João Conde, Róbert Langer, José Rueff · 2023 · Nature Nanotechnology